Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan
· Delayed Price · Currency is TWD 82.90
-1.80 (-2.13%)
Apr 24, 2025, 1:30 PM CST
Gongwin Biopharm Holdings Revenue
In the year 2024, Gongwin Biopharm Holdings had annual revenue of 32.04M TWD with 69.39% growth. Gongwin Biopharm Holdings had revenue of 8.92M in the quarter ending December 31, 2024, with 3.19% growth.
Revenue
32.04M
Revenue Growth
+69.39%
P/S Ratio
326.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.04M | 13.13M | 69.39% |
| Dec 31, 2023 | 18.92M | 17.77M | 1,554.86% |
| Dec 31, 2022 | 1.14M | - | - |
| Dec 31, 2021 | 1.14M | 310.00K | 37.21% |
| Dec 31, 2020 | 833.00K | 585.00K | 235.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |